RAPT Therapeutics
Biotechnology ResearchView the employees at
RAPT Therapeutics-
Dusty Burdette Production Control Manager at RAPT
-
Rising Star
Anthony Ramey machine operater at Rapt-
Richmond, Kentucky, United States
-
Rising Star
freddie mloyiswa mutswairo programme Officer at RAPT-
Zimbabwe
-
Top 5%
Edna Jackson machine operator at Rapt-
Richmond, Kentucky, United States
-
Rising Star
Sriram Hathwar Computational Biologist @ RAPT Therapeutics-
San Francisco, California, United States
-
Rising Star
Overview
RAPT Therapeutics is a clinical stage immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. RAPT has discovered and advanced two unique drug candidates, RPT193 and FLX475, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of inflammation and cancer, respectively. The company is also pursuing a range of targets that are in the discovery stage of development.
-